RxDoctor Payments Data

Srihari Daggumati, MD

Otolaryngology · Marlton, NJNPI 1902466527

Payments from drug & device makers

What this record shows

Stryker accounts for 72.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $2,785 and has fallen 74.2% since, to $719 in 2025.

$4,147in general payments, 2019–2025

Across 48 payments — averaging $86.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Medtronic$420
  • Sanofi$199
  • Integra Lifesciences Corporation$145
  • Regeneron$140
  • Regeneron Healthcare Solutions, Inc.$125
  • plus $98 from 4 others

What the payments were for

  • Travel & lodging$1,97948%
  • Food & beverage$2,16952%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,147 in reported general payments places this provider in the 85th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$12,110
Medicare patients
33
Services billed
74

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otolaryngology in Marlton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →